Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

8.51
-0.2500-2.85%
Post-market: 8.930.4200+4.94%17:52 EDT
Volume:110.59K
Turnover:954.58K
Market Cap:279.12M
PE:-10.27
High:8.78
Open:8.74
Low:8.49
Close:8.76
Loading ...

Company Profile

Company Name:
NeuroPace Inc.
Exchange:
NASDAQ
Establishment Date:
1997
Employees:
195
Office Location:
455 North Bernardo Avenue,Mountain View,California,United States
Zip Code:
94043
Fax:
650 237 2701
Introduction:
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Directors

Name
Position
Frank Fischer
Chairman of the Board
Joel Becker
Director, President and Chief Executive Officer
Joseph Lacob
Independent Director
Lisa Andrade
Independent Director
Rakhi Kumar
Independent Director
Renee Ryan
Independent Director
Uri Geiger
Independent Director
Richard Scott Huennekens
Director

Shareholders

Name
Position
Joel Becker
Director, President and Chief Executive Officer
Patrick F. Williams
Chief Financial Officer
Martha Morrell
Chief Medical Officer